Menu Search
Equities

Aesthetic Medical International Holdings Group Ltd

3FMA:FRA

Aesthetic Medical International Holdings Group Ltd

Actions
  • Price (EUR)0.123
  • Today's Change-0.022 / -15.17%
  • Shares traded3.00k
  • 1 Year change-84.03%
  • Beta--
Data delayed at least 15 minutes, as of May 31 2024 14:29 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Aesthetic Medical International Holdings Group Limited is a company that provides aesthetic medical services. The Company is principally engaged in three businesses. Surgical aesthetic treatments services include eye surgery, rhinoplasty, breast augmentation and liposuction. Non-surgical aesthetic treatments services, which comprise minimally invasive treatments and energy-based treatments such as laser, ultrasound and ultraviolet light treatments. Other aesthetic services include cosmetic dentistry and general medical services. The Company operates its businesses primarily in the domestic market.

  • Revenue in USD (TTM)94.26m
  • Net income in USD-5.17m
  • Incorporated--
  • Employees1.29k
  • Location
    Aesthetic Medical International Holdings Group Ltd4068 Qiaoxiang Road, Nanshan DistrictSHENZHEN 518053ChinaCHN
  • Phone+86 9 176090333
  • Websitehttp://www.pengai.com.cn
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.